Literature DB >> 2938858

Antigen-specific and polyclonal B-cell responses in patients with acquired immunodeficiency disease syndrome.

I R Katz, S E Krown, B Safai, H F Oettgen, M K Hoffmann.   

Abstract

Patients with acquired immunodeficiency disease syndrome (AIDS) show a complex spectrum of immunological abnormalities. We have examined B-lymphocyte function in 58 patients with AIDS and Kaposi's sarcoma. The major finding has been that the specific antibody response to sheep red blood cell antigen in vitro is severely depressed. Analysis of the defect in specific antibody production indicates that it is not caused by lack of T-cell help or excessive T-cell suppression, and suggests that it reflects an abnormality of the B-cell compartment itself. The defect does not affect the ability of B cells to respond to polyclonal stimulation. The possibility is considered that continuous hyperactivation of B cells in AIDS patients (as reflected in the increase in both immunoglobulin-secreting cells and serum immunoglobulin levels) results in depletion of the pool from which precursors for antigen specific B-cell responses are normally recruited.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2938858     DOI: 10.1016/0090-1229(86)90164-9

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  15 in total

Review 1.  Cytokines as adjuvants for vaccines: antigen-specific responses differ from polyclonal responses.

Authors:  C E Taylor
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

2.  Lymphocyte autoantibodies and alloantibodies in HIV-positive haemophilia patients.

Authors:  V Daniel; K Schimpf; G Opelz
Journal:  Clin Exp Immunol       Date:  1989-02       Impact factor: 4.330

3.  Peripheral blood dendritic cells in persons with AIDS and AIDS related complex: loss of high intensity class II antigen expression and function.

Authors:  L J Eales; J Farrant; M Helbert; A J Pinching
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

4.  Persistence of HIV-1 structural proteins and glycoproteins in lymph nodes of patients under highly active antiretroviral therapy.

Authors:  Mikulas Popovic; Klara Tenner-Racz; Colleen Pelser; Hans-Jurgen Stellbrink; Jan van Lunzen; George Lewis; Vaniambadi S Kalyanaraman; Robert C Gallo; Paul Racz
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

5.  Serial study of CD5+ and CD5- B cell subpopulations in 335 HIV seropositive patients.

Authors:  F Vuillier; D Scott-Algara; P Tortevoye; G Pialoux; G Dighiero
Journal:  Clin Exp Immunol       Date:  1991-09       Impact factor: 4.330

6.  Circulating immune complexes and analysis of renal immune deposits in feline immunodeficiency virus-infected cats.

Authors:  A Poli; M L Falcone; L Bigalli; C Massi; R Hofmann-Lehmann; S Lombardi; M Bendinelli; H Lutz
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

7.  Urinary tract infection in men with AIDS.

Authors:  A M De Pinho; G S Lopes; C F Ramos-Filho; O da R Santos; M P De Oliveira; M Halpern; C A Gouvea; M Schechter
Journal:  Genitourin Med       Date:  1994-02

8.  Phenotypical and functional evaluation of CD8+/S6F1+ T lymphocytes in haemophiliac individuals with HIV-1 infection.

Authors:  F Cavallin; A Traldi; R Zambello
Journal:  Clin Exp Immunol       Date:  1993-07       Impact factor: 4.330

9.  Noninfectious X4 but not R5 human immunodeficiency virus type 1 virions inhibit humoral immune responses in human lymphoid tissue ex vivo.

Authors:  Wendy Fitzgerald; Andrew W Sylwester; Jean-Charles Grivel; Jeffrey D Lifson; Leonid B Margolis
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

10.  An early defect in primary and secondary T cell responses in asymptomatic cats during acute feline immunodeficiency virus (FIV) infection.

Authors:  S A Bishop; N A Williams; T J Gruffydd-Jones; D A Harbour; C R Stokes
Journal:  Clin Exp Immunol       Date:  1992-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.